Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors
Erstveröffentlichung
2015
Wissenschaftlicher Artikel
Published in
Expert Opinion on Drug Metabolism and Toxicology ; 11 (2015), 8. - S. 1219-1232. - ISSN 1742-5255. - eISSN 1744-7607
Link to publication
https://dx.doi.org/10.1517/17425255.2015.1052791Institutions
UKU. Institut für Naturheilkunde und Klinische PharmakologieUKU. Klinik für Psychiatrie und Psychotherapie III
Subject headings
[Free subject headings]: antidepressant/SSRI | Cytochrome P450/CYP | metabolism/response/side effects/adverse reactions/outcome | pharmacogenetic | pharmacogenomics | pharmacokinetic | STATE PLASMA-CONCENTRATIONS | CYP1A2 GENETIC POLYMORPHISMS | 2D6 GENOTYPE | ANTIDEPRESSANT ESCITALOPRAM | CYP2C19-ASTERISK-17 ALLELE | CONCENTRATION/DOSE RATIO | ULTRARAPID METABOLISM | SERUM CONCENTRATIONS | CYP2C19 VARIATION | FLUVOXAMINO ACID[DDC subject group]: DDC 570 / Life sciences | DDC 610 / Medicine & health